HeXell-2020

N/A

Report date: 2025/08/28 20:00:09

Base Information

Drug NameHeXell-2020

Drug Alias NameHeXell-2020

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsFrailtyCoronary Artery Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesHexun Biosciences Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHexun Biosciences Co Ltd

Inactive CompaniesN/A

Active IndicationsFrailtyCoronary Artery Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A